Insmed | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Cytokinetics USD 94.86M 47.97M 2024-12
DBV Technologies USD 32.5M 4.51M 2024-12
Dynavax Technologies USD 95.88M 23.45M 2024-12
Gilead Sciences USD 9.99B 4.95B 2024-12
Insmed USD 555.03M 93.58M 2024-12
Novartis USD 11.46B 2.15B 2024-12
Regeneron Pharmaceuticals USD 17.91B 15.9B 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Insmed Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.